Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tacrolimus in dermatologic disorders.

P A Skaehill1

  • 1Mercy Health Center, Southwestern Oklahoma State University, Oklahoma City 73120, USA. skaehip@swosu.edu

The Annals of Pharmacotherapy
|May 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug-induced lichen planus.

Pharmacotherapy·1994
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
See all related articles

Topical tacrolimus is a safe and effective treatment for inflammatory skin disorders like atopic dermatitis. Oral tacrolimus shows efficacy but has significant side effects, limiting its use.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Tacrolimus is an immunomodulatory agent.
  • Skin disorders often involve immune system dysregulation.
  • Existing treatments may have limitations, necessitating alternative therapies.

Purpose of the Study:

  • To review existing data on tacrolimus for various skin conditions.
  • To evaluate the efficacy and safety of topical and oral tacrolimus.
  • To determine the therapeutic potential and limitations of tacrolimus in dermatology.

Main Methods:

  • Literature search of English-language articles from 1990-2000.
  • Inclusion of original human studies on tacrolimus for skin disorders.
  • Extraction of patient response and adverse effect data.

Related Experiment Videos

Main Results:

  • Topical tacrolimus is safe and effective for atopic dermatitis and other inflammatory skin conditions.
  • Oral tacrolimus demonstrates efficacy in conditions like psoriasis but carries risks.
  • Adverse effects of oral tacrolimus include infections, hypertension, and potential neoplasia.

Conclusions:

  • Short-term topical tacrolimus is a viable option for inflammatory skin disorders.
  • Long-term safety and optimal dosing of topical tacrolimus require further investigation.
  • Oral tacrolimus is a potential third-line therapy due to its adverse effect profile.